Montreal Immune-Related Adverse Events (MIRAE) Study

Clinical trial NCT05139706 · RECRUITING

Trial details

NCT number: NCT05139706
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer Immune System Disorder Inflammatory Reaction Autoimmune Diseases

Start date: 2020-01-21
Primary completion: 2030-01-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.